Journal of Medical Economics, Volume 19, Issue 12 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 19, Issue 12 (2016)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Volume 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Urology

Article
Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe
Lewis Ruff, Emma Bagshaw, Javier Aracil, Marie-Eve Velard, Gianni Pardhanani & Zsolt Hepp
Pages: 1107-1115
Published online: 15 Jul 2016
AbstractforEconomic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe | Full Text | References | PDF (933.8 KB)
  • 1691 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Renal

Article
The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD)
John C. Kingswood, Paola Nasuti, Keyur Patel, Melissa Myland, Vathani Siva & Elizabeth Gray
Pages: 1116-1126
Published online: 25 Jun 2016
AbstractforThe economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD) | Full Text | References | PDF (983.4 KB)
  • 1475 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective
L. H. Chuang, B. G. Verheggen, M. Charokopou, D. Gibson, S. Grandy & B. Kartman
Pages: 1127-1134
Published online: 28 Jun 2016
AbstractforCost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective | Full Text | References | PDF (745.9 KB)
  • 3770 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Urology

Article
Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives
Ronald C. Wielage, Sinem Perk, Noll L. Campbell, Timothy M. Klein, Linda M. Posta, Thomas Yuran, Robert W. Klein & Daniel B. Ng
Pages: 1135-1143
Published online: 04 Jul 2016
AbstractforMirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives | Full Text | References | PDF (1 MB)
  • 1302 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan
Suchin Virabhak, Kikuo Yasui, Kiyotaka Yamazaki, Scott Johnson, Dominic Mitchell, Cammy Yuen, Jennifer C. Samp & Ataru Igarashi
Pages: 1144-1156
Published online: 25 Jul 2016
AbstractforCost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan | Full Text | References | PDF (1.4 MB)
  • 860 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
A societal cost-of-illness study of hemodialysis in Lebanon
Rana Rizk, Mickaël Hiligsmann, Mirey Karavetian, Pascale Salameh & Silvia M. A. A. Evers
Pages: 1157-1166
Published online: 14 Jul 2016
AbstractforA societal cost-of-illness study of hemodialysis in Lebanon | Full Text | References | PDF (1.1 MB)
  • 987 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes
J. Gordon, P. McEwan, U. Sabale, B. Kartman & B. H. R. Wolffenbuttel
Pages: 1167-1174
Published online: 09 Aug 2016
AbstractforThe cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes | Full Text | References | PDF (783.3 KB) | Supplemental
  • 746 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States
Jennifer Cai, Yuexi Wang, Onur Baser, Lin Xie & Wing Chow
Pages: 1175-1186
Published online: 12 Jul 2016
AbstractforComparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States | Full Text | References | PDF (1.8 MB)
  • 2426 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico
Namita Tundia, Paulo Gustavo Kotze, Jorge Rojas Serrano, Mirhelen Mendes de Abreu, Martha Skup, Dendy Macaulay, James Signorovitch, Leonardo Chaves, Jingdong Chao & Yanjun Bao
Pages: 1187-1199
Published online: 19 Jul 2016
AbstractforEconomic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico | Full Text | References | PDF (1.7 MB)
  • 1012 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Urology

Article
Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults
Fredrik Andersson, Peter Anderson, Tove Holm-Larsen, James Piercy, Karel Everaert & Tim Holbrook
Pages: 1200-1206
Published online: 26 Jul 2016
AbstractforAssessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults | Full Text | References | PDF (581.2 KB)
  • 836 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
Amino acid formula as a new strategy for diagnosing cow’s milk allergy in infants: is it cost-effective?
Mauro Batista de Morais, José Vicente Spolidoro, Mário César Vieira, Ary Lopes Cardoso, Otavio Clark, Alvaro Nishikawa & Ana Paula Moschione Castro
Pages: 1207-1214
Published online: 21 Jul 2016
AbstractforAmino acid formula as a new strategy for diagnosing cow’s milk allergy in infants: is it cost-effective? | Full Text | References | PDF (728.3 KB) | Supplemental
  • 1186 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles